DK0973790T3 - Estra-5(10),7-diener med østrogen aktivitet - Google Patents

Estra-5(10),7-diener med østrogen aktivitet

Info

Publication number
DK0973790T3
DK0973790T3 DK98915224T DK98915224T DK0973790T3 DK 0973790 T3 DK0973790 T3 DK 0973790T3 DK 98915224 T DK98915224 T DK 98915224T DK 98915224 T DK98915224 T DK 98915224T DK 0973790 T3 DK0973790 T3 DK 0973790T3
Authority
DK
Denmark
Prior art keywords
estra
dienes
estrogenic activity
estrogenic
activity
Prior art date
Application number
DK98915224T
Other languages
Danish (da)
English (en)
Inventor
Leonard Alexander Mcdonald
Michael Z Kagan
Syed Muzafar Shah
Panolil Raveendranath
Mark Andrew Collins
Fangming Kong
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Application granted granted Critical
Publication of DK0973790T3 publication Critical patent/DK0973790T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J21/005—Ketals
    • C07J21/008—Ketals at position 17
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0059—Estrane derivatives substituted in position 17 by a keto group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J17/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J17/005—Glycosides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK98915224T 1997-04-07 1998-04-02 Estra-5(10),7-diener med østrogen aktivitet DK0973790T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US83533697A 1997-04-07 1997-04-07
US85057097A 1997-05-02 1997-05-02
PCT/US1998/006461 WO1998045315A1 (en) 1997-04-07 1998-04-02 Estra-5(10),7-dienes with estrogenic activity

Publications (1)

Publication Number Publication Date
DK0973790T3 true DK0973790T3 (da) 2003-09-22

Family

ID=27125779

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98915224T DK0973790T3 (da) 1997-04-07 1998-04-02 Estra-5(10),7-diener med østrogen aktivitet

Country Status (15)

Country Link
EP (1) EP0973790B1 (de)
JP (1) JP2001518896A (de)
KR (1) KR20010006118A (de)
CN (1) CN1259137A (de)
AR (1) AR012341A1 (de)
AT (1) ATE242263T1 (de)
AU (1) AU738486B2 (de)
BR (1) BR9809748A (de)
CA (1) CA2286457A1 (de)
DE (1) DE69815329T2 (de)
DK (1) DK0973790T3 (de)
ES (1) ES2200334T3 (de)
NZ (1) NZ500217A (de)
PT (1) PT973790E (de)
WO (1) WO1998045315A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2441252A1 (en) * 2001-03-16 2002-10-10 Wyeth Estrogen replacement therapy
WO2009120678A2 (en) * 2008-03-24 2009-10-01 Signa Chemistry, Llc Birch reduction of steroid substrates via alkali metal-silica gel materials
PE20150353A1 (es) 2012-07-10 2015-03-28 Bayer Pharma AG Derivados de estra-1,3,5(10),16-tetraeno 3-sustituidos, metodos para su preparacion, preparaciones farmaceuticas que los contienen, asi como su uso para la preparacion de medicamentos
AP3826A (en) 2013-02-21 2016-09-30 Bayer Pharma Aktiengellschaft Estra-1,3,5(10),16-tetraene-3-carboxamides for inhibition of 17.beta.-hydroxysteroid dehydrogenase (akr1 c3)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1093360B (de) * 1958-02-17 1960-11-24 Ayerst Mckenna & Harrison Verfahren zur Herstellung von stabilen antioestrogen wirksamen Verbindungen der Oestranreihe
US2930805A (en) * 1959-01-19 1960-03-29 American Home Prod Novel derivatives of estrane
US3340278A (en) * 1965-05-03 1967-09-05 American Home Prod 5(10), 7-estradiene-3, 17-dione and the process for the production thereof
ES2090861T3 (es) * 1992-04-07 1996-10-16 Neurim Pharma 1991 Utilizacion de melatonina para la preparacion de un medicamento para el tratamiento de la hiperplasia de prostata benigna.

Also Published As

Publication number Publication date
DE69815329T2 (de) 2004-04-29
EP0973790A1 (de) 2000-01-26
CA2286457A1 (en) 1998-10-15
BR9809748A (pt) 2000-06-20
AU738486B2 (en) 2001-09-20
ATE242263T1 (de) 2003-06-15
KR20010006118A (ko) 2001-01-26
AR012341A1 (es) 2000-10-18
WO1998045315A1 (en) 1998-10-15
ES2200334T3 (es) 2004-03-01
CN1259137A (zh) 2000-07-05
DE69815329D1 (de) 2003-07-10
AU6946298A (en) 1998-10-30
JP2001518896A (ja) 2001-10-16
EP0973790B1 (de) 2003-06-04
PT973790E (pt) 2003-10-31
NZ500217A (en) 2001-11-30

Similar Documents

Publication Publication Date Title
DE69723886D1 (de) Dünne,komfortable,interlabiale absorbierende struktur
NO2006016I1 (no) 7,8,9,10-tetrahydro-6H-6,10-metanoazepinoÄ4,5-gÜkinoksalintartrat
PT993456E (pt) 4,5-diaril-imidazoles 2-substituidos
NL300416I1 (nl) Estrogene middelen
NO971814D0 (no) Östrogene midler
DE69805643D1 (de) Membrane-elektroden-anordnung
NL300150I2 (nl) 4 "-Gesubstitueerde 9-deoxo-9A-AZA-9A-homoërythromycine-A-derivaten.
ID21413A (id) Turunan-turunan 1,3,8,-triaza-spiro (4,5) dekan-4-on
DK0973790T3 (da) Estra-5(10),7-diener med østrogen aktivitet
FI1592U1 (fi) Spruta, foeretraedesvis injektionsspruta
DE69829900D1 (de) Neigungsverstellvorrichtung
DK1068200T3 (da) 2,4,4-trisubstituerede-1,3-dioxolanfungicider
ID24047A (id) Turunan 5-tersubstitusi-3-oksaziazolil 1,6-naftiridin-2 1h-on
DE59508591D1 (de) 2-arylcyclopentan-1,3-dion-derivate
IT1268116B1 (it) Sedia.
IT235750Y1 (it) Sci.
ES1029350Y (es) Nueva estructura de asiento.
FI971570A0 (fi) Styrsystem foer foerbraenningsluften i en ackumulerande, vedeldad eldstad
FI944648A0 (fi) Bromsmekanism foer fordon, saerskilt foer en cykel
FIU940180U0 (fi) Baotstege, kaerra, landgaong
FI945785A0 (fi) Pimpelspoe, fiskeredokap
ES1039107Y (es) Seccionador perfeccionado.
ES1036188Y (es) Humidificador perfeccionado.
ID19473A (id) 24-homo-26,27-heksafluoro-kolkalsiferol
FI971391A0 (fi) Koppling laemplig foer spaenningsarbete, saerskilt koppling foer ljusbaogs- eller oeverstoemsskydd